Automated And Closed Cell Therapy Processing Systems Market Size Forecast: How The Industry Is Expected To Grow From 2026 To 2030
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Automated And Closed Cell Therapy Processing Systems Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The automated and closed cell therapy processing systems market has seen rapid expansion in recent years. This market is set to increase from $1.53 billion in 2025 to $1.8 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.6%. Historically, its growth can be linked to aspects such as manual cell processing methods, high contamination risks, limited workflow automation, reliance on traditional bioreactors, and the slow adoption of regenerative therapies.
The automated and closed cell therapy processing systems market size is anticipated to experience swift expansion over the coming years. It is projected to reach $3.34 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 16.7%. This expansion during the projection period stems from factors such as the creation of integrated closed-system platforms, innovations in robotics and microfluidics, the expanding number of cell and gene therapy pipelines, stricter regulatory compliance benchmarks, and the proliferation of contract manufacturing organizations (cramos) specializing in cell therapies. Key trends expected within this period encompass a greater uptake of single-use and closed systems, a surge in demand for automated cell therapy processes, an emphasis on reducing contamination and improving safety, the incorporation of multi-step cell processing platforms, and the broadened application in regenerative medicine and oncology.
Get A Free Sample Report With In-Depth Market Insights:
Automated And Closed Cell Therapy Processing Systems Market Demand Drivers Opening New Revenue Streams
The increasing need for individualized treatment approaches is projected to drive expansion within the automated and closed-cell therapy processing systems market in the future. Individualized medicine encompasses medical interventions specifically adapted to a patient’s genetic, molecular, or cellular makeup, aiming to optimize effectiveness and reduce negative side effects. This rising demand for personalized medicine stems from fortified regulatory structures and motivators that favor the authorization of targeted and curative treatments over widely applicable medications. Automated and closed-cell therapy processing systems facilitate personalized medicine by allowing producers to create consistent, high-standard, patient-specific cell therapies that adhere to rigorous regulatory requirements. For instance, in May 2025, according to the Personalized Medicine Coalition (PMC), a US-based non-profit organization, the FDA approved 18 new personalized medicines in 2024, including six gene- or cell-based therapies, representing roughly 38 percent of all new molecular entities. Consequently, the increasing requirement for personalized medicine is fueling the expansion of the automated and closed-cell therapy processing systems market.
Automated And Closed Cell Therapy Processing Systems Market Segments: Where Is Growth Concentrated?
The automated and closed cell therapy processing systems market covered in this report is segmented –
1) By Component: Software, Hardware, Consumables
2) By Technology: Microfluidics, Robotics, Bioreactors, Single-Use Technology, Three-Dimensional (3D) Cell Culture
3) By Workflow: Cryopreservation, Separation, Fill-Finish, Expansion, Apheresis, Other Workflows
4) By Application: Oncology, Regenerative Medicine, Autoimmune Diseases, Infectious Diseases, Cardiovascular Diseases
5) By End User: Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Contract Manufacturing Organizations, Hospitals
Subsegments:
1) By Software: Process Control Software, Data Management Software, Quality Monitoring Software, Workflow Automation Software, Integration Software
2) By Hardware: Cell Separation Devices, Bioreactors, Fluid Handling Systems, Centrifuges, Tubing And Connectors
3) By Consumables: Sterile Bags, Culture Media, Reagents And Buffers, Filters And Cartridges, Single-Use Tubing Sets
Automated And Closed Cell Therapy Processing Systems Market Trends Powering Strategic Industry Growth
Companies operating within the automated and closed cell therapy processing systems market are prioritizing the creation of advanced solutions, including cell preparation platforms, to diminish the need for manual labor and the potential for contamination during cell processing. Cell preparation platforms are automated systems specifically designed to efficiently isolate, process, and prepare cells for subsequent analysis or clinical application. For example, in October 2024, Sino-Biocan Biotechnology Ltd., a China-based biotech company, unveiled the WUKONG Automated, Closed, Integrated Cell Processing System. This system represents a significant progression in cell therapy manufacturing, providing an entirely automated, closed platform that streamlines operations from blood collection to cell culture and final filling. It is engineered to serve hospitals, pharmaceutical research and development teams, and contract development and manufacturing organizations by boosting efficiency, lowering contamination risks, and guaranteeing good manufacturing practice-grade consistency through smart controls and continuous monitoring.
Automated And Closed Cell Therapy Processing Systems Market Leading Players And Competitive Positioning
Major companies operating in the automated and closed cell therapy processing systems market are Thermo Fisher Scientific Inc., Fresenius SE & Co. KGaA, Danaher Corporation, Merck KGaA, Parker Hannifin Corp., Corning Incorporated, Kawasaki Heavy Industries Ltd., Dover Corporation, Lonza Group AG, Terumo Corporation, Sartorius AG, Charles River Laboratories International Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Hamilton Company, Repligen Corporation, Cellares Inc., Ori Biotech Ltd., Autolus Therapeutics Plc.
View The Full Automated And Closed Cell Therapy Processing Systems Market Report:
Automated And Closed Cell Therapy Processing Systems Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the automated and closed cell therapy processing systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated and closed cell therapy processing systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
